Breast Cancer Vaccine
This is an editorial from the Huffington Post by Fran Visco, the director of the NBCC, As you likely know, NBCC is committed to ending breast cancer by the end of this decade. One research interest, in cancer in general, is vaccines. Be forewarned: although there has been a lot of promise associated with this approach, no vaccine has yet delivered much.
Here is the begining and then a link:
Fran Visco National Breast Cancer Coalition President
March 14, 2012
Aiming for the Bullseye: A Breast Cancer Vaccine Posted: 03/ 7/2012 3:46 pm
I am on a flight right now headed home from the second annual meeting of NBCC's Artemis Project® to develop a breast cancer preventive vaccine. I find myself extremely excited about the spirit of collaboration and innovation among the participants. I am impressed with the eagerness of all in attendance to think beyond their own work, to figure out the barriers to progress and to design strategies to overcome them.
I am also a bit overwhelmed at the moment as I review the weekend and anticipate the very hard work to come to make real the plans developed over the past few days. I have been thinking about a letter the National Breast Cancer Coalition sent to breast cancer clinicians and researchers last year asking them to imagine, just for a moment, what it would be like if we all collaborated toward the common goal of meeting our deadline to end breast cancer by January 1, 2020. In that letter, we asked what barriers they believed we needed to remove. We asked what they thought we could change and what they saw as the steps we needed to take to achieve our goal.
This weekend, as I sat among advocates from around the country and researchers from institutions including Cold Spring Harbor Laboratory, City of Hope Beckman Research Institute, the Mayo Clinic, University of Pennsylvania, the Whitehead Institute and several others -- all of us immersed in the challenges and opportunities in front of us -- we did exactly what I'd hoped when we set a deadline to end this disease. We worked together toward one common goal -- to end breast cancer by the end of the decade.